Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE.

To understand the molecular basis for the differences in receptor-binding activity of the three common human apolipoprotein E (apoE) isoforms, we characterized the microenvironments of their LDL receptor (LDLR)-binding regions (residues 136;-150). When present in dimyristoyl phosphatidylcholine (DMPC) complexes, the 22-kDa amino-terminal fragments (residues 1;-191) of apoE3 and apoE4 bound to the LDLR with approximately 100-fold greater affinity than the 22-kDa fragment of apoE2. The pK(a) values of lysines (K) at positions 143 and 146 in the LDLR-binding region in DMPC-associated 22-kDa apoE fragments were 9.4 and 9.9 in apoE2, 9.5 and 9.2 in apoE3, and 9.9 and 9.4 in apoE4, respectively. The increased pK(a) of K146 in apoE2 relative to apoE3 arises from a reduction in the positive electrostatic potential in its microenvironment. This effect occurs because C158 in apoE2, unlike R158 in apoE3, rearranges the intrahelical salt bridges along the polar face of the amphipathic alpha-helix spanning the LDLR-binding region, reducing the effect of the R150 positive charge on K146 and concomitantly decreasing LDLR-binding affinity. The C112R mutation in apoE4 that differentiates it from apoE3 did not perturb the pK(a) of K146 significantly, but it increased the pK(a) of K143 in apoE4 by 0.4 pH unit. This change did not alter LDLR-binding affinity. Therefore, maintaining the appropriate positive charge at the C-terminal end of the receptor-binding region is particularly critical for effective interaction with acidic residues on the LDLR.

[1]  K. Weisgraber,et al.  The carboxyl terminus in apolipoprotein E2 and the seven amino acid repeat in apolipoprotein E-Leiden: role in receptor-binding activity. , 1998, Journal of lipid research.

[2]  D. Dearborn,et al.  [50] Protein labeling by reductive alkylation , 1983 .

[3]  Sean Parkin,et al.  Conformational flexibility in the apolipoprotein E amino‐terminal domain structure determined from three new crystal forms: Implications for lipid binding , 2000, Protein science : a publication of the Protein Society.

[4]  R. Mahley,et al.  Human apolipoprotein E: the Alzheimer's disease connection , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  L. Sokoloff,et al.  Sterol to Phospholipid Molar Ratios of L Cells with Qualitative and Quantitative Variations of Cellular Sterol , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[6]  K. Weisgraber,et al.  Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli. , 1999, Protein expression and purification.

[7]  D. Sparks,et al.  The conformation of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. 13C NMR studies of lysine ionization behavior. , 1992, The Journal of biological chemistry.

[8]  Suzanne Wehrli,et al.  Effects of Lipid Interaction on the Lysine Microenvironments in Apolipoprotein E* , 2000, The Journal of Biological Chemistry.

[9]  K. Weisgraber,et al.  Conformational Reorganization of the Four-helix Bundle of Human Apolipoprotein E in Binding to Phospholipid* , 2000, The Journal of Biological Chemistry.

[10]  R. Mahley,et al.  Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. , 1999, Current opinion in lipidology.

[11]  D A Agard,et al.  Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. , 1991, Science.

[12]  D. Agard,et al.  Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein. , 1994, Structure.

[13]  K. Wüthrich,et al.  Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. , 1983, Biochemical and biophysical research communications.

[14]  R. Ryan,et al.  Lipid binding-induced conformational changes in the N-terminal domain of human apolipoprotein E. , 1999, Journal of lipid research.

[15]  E. Quinet,et al.  Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. , 1980, The Journal of clinical investigation.

[16]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[17]  R. Mahley,et al.  Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. , 1982, The Journal of biological chemistry.

[18]  Sean Parkin,et al.  Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia , 1996, Nature Structural Biology.

[19]  M C Phillips,et al.  A 13C NMR characterization of lysine residues in apolipoprotein B and their role in binding to the low density lipoprotein receptor. , 1988, The Journal of biological chemistry.

[20]  L. Kuller,et al.  Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. , 1993, The American journal of cardiology.

[21]  R. Mahley,et al.  Conformation of apolipoprotein E in lipoproteins. , 1993, The Journal of biological chemistry.

[22]  F. Richards,et al.  1H-15N heteronuclear NMR studies of Escherichia coli thioredoxin in samples isotopically labeled by residue type. , 1985, Biochemistry.

[23]  L W Jelinski,et al.  Nuclear magnetic resonance spectroscopy. , 1995, Academic radiology.

[24]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[25]  D. Agard,et al.  Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. , 1994 .

[26]  R A Sayle,et al.  RASMOL: biomolecular graphics for all. , 1995, Trends in biochemical sciences.

[27]  D. Dearborn,et al.  Protein labeling by reductive alkylation. , 1983, Methods in enzymology.

[28]  K. Weisgraber Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. , 1990, Journal of lipid research.

[29]  R. Mahley,et al.  The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments. , 1983, The Journal of biological chemistry.

[30]  K. Weisgraber,et al.  Apolipoprotein E–low density lipoprotein receptor interaction: influences of basic residue and amphipathic α-helix organization in the ligand , 2000 .

[31]  R. Epand The Amphipathic Helix , 1993 .

[32]  K. Weisgraber Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.

[33]  J. Roberts,et al.  Nuclear magnetic resonance spectroscopy. Carbon-13 chemical shifts of small peptides as a function of pH. , 1972, Journal of the American Chemical Society.

[34]  R. Mahley,et al.  Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. , 1999, Journal of lipid research.

[35]  C. Grubmeyer,et al.  Primary structure and crystallization of orotate phosphoribosyltransferase from Salmonella typhimurium. , 1993, Journal of molecular biology.

[36]  R. Mahley,et al.  Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. , 1979, The Journal of biological chemistry.

[37]  R. Mahley,et al.  Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. , 1999, Journal of lipid research.

[38]  K. Wüthrich,et al.  Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. , 1983, Biochemical and biophysical research communications.

[39]  R. Mahley,et al.  Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation. , 1984, The Journal of biological chemistry.

[40]  D. Arveiler,et al.  Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[41]  S. Blacklow,et al.  Solution structure of the sixth LDL-A module of the LDL receptor. , 2000, Biochemistry.